Semper Paratus (Nasdaq: LGST) announced this morning that its shareholders approved its combination with Tevogen Bio during a special meeting yesterday January 31.
In connection with the vote, shareholders holding 1,432,457 shares out of a possible 1,502,180 Semper Paratus ordinary shares opted to redeem their shares. While the final amount of the funds to be removed from the trust is still being calculated, the current preliminary calculations are that approximately $15.9 million, or $11.07 per share, will be removed from the trust.
Including prior votes, LGST shareholders have redeemed an aggregate of 99.8% of the SPAC’s trust thus far, leaving it with roughly $800,000 and 69,723 shares remaining.
The parties did not provide a timeline for the closing of the deal, but it is expected to be completed as soon as practicable following the satisfaction of the remaining closing conditions, including approval for listing on The Nasdaq.
Following the closing of the deal, the common stock of the combined company is expected to begin trading on Nasdaq under the symbol “TVGN”.
Semper Paratus inked its $1.2 billion deal with Tevogen Bio in June 2023. Warren, New Jersey-based Tevogen is developing a treatment to boost the immune systems of COVID patients undergoing cancer treatments or that have other comorbidities.
All other proposals presented on the ballot were also approved at the meeting .
Best SPAC I (NASDAQ:BSAAU) has filed for a $55 million SPAC with a search focus targeting consumer goods companies from its base in Hong Kong. Maxim is taking just 1.0% fees up front and will not take a deferred fee. This upfront fee will also apply only to proceeds in the offering from investors brought...
At the SPAC of Dawn Two new SPACs priced their IPOs yesterday, showing that SPACs at least are not entirely spooked by the markets continued downturn. Futures continue to be beet red heading into the second day of the week, particularly for the SPAC-favorite exchange Nasdaq. SPACs have the potential to shine in this environment,...
An In-Depth Look at SPAC Activity Through the First Quarter 2025 Below is a summary of the Q1-2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. While SPAC IPO issuance has continued to climb modestly in Q1, it’s doing so at a more sustainable and disciplined pace compared to...
Siddhi Acquisition Corp. (NASDAQ:SDHIU) announced the pricing of its upsized $240 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SDHIU”, Tuesday, April 1, 2025. The new SPAC plans to mount a broad search for a target company leveraging its internal network of relationships. Siddhi is to be...
UY Scuti Acquisition Corp. (NASDAQ:UYSCU) announced the pricing of its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “UYSCU”, Tuesday, April 1, 2025. The new SPAC aims to combine with a target company in Asia, but it does not have a specific preference on industry or...